Union Therapeutics’ Acquisition of LEO’s PDE4i Compound Class

Plesner assisted Union therapeutics A/S. UNION therapeutics announced the acquisition of the global rights for the LEO PDE4 inhibitor compound series, a series of PDE4 inhibitors…